Año: 2023
Journal Impact Factor (JIF): 6.10
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| ONCOLOGY | SCIE | 49/322 | Q1 | T1 | D2 |
Año: 2023
Journal Citation Indicator (JCI): 1,400
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| ONCOLOGY | 47/322 | Q1 | T1 | D2 | 85,56 |
Año:
2023
CiteScore:
12,000
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 37/230 | Q1 | T1 | D2 |
| Oncology | 45/404 | Q1 | T1 | D2 |
SJR año:
2023
Factor de Impacto:
2,578
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Cancer Research | 33/233 | Q1 | T1 | D2 |
| Oncology | 40/397 | Q1 | T1 | D2 |
| Agencia | Código de Proyecto |
|---|---|
| Astex Pharmaceuticals | - |
| Novartis | - |
| Novartis Institutes for BioMedical Research | - |
| The study was sponsored by Novartis. We thank the patients who participated in this trial, their families, and their caregivers; members of the data monitoring committee; members of the study steering committee; staff members who helped with the trial at e | - |
| # | Autor | Afiliación |
|---|---|---|
| 1 | KU Leuven– University Hospital Leuven (Belgium) | |
| 2 | Fasching, P. A. | Universitätsklinik Erlangen und Medizinische Fakultät (Germany) |
| 3 | Chia, S. | British Columbia Cancer Agency (Canada) |
| 4 | Jerusalem, G. | Centre Hospitalier Universitaire de Liege (Belgium) |
| 5 | De Laurentiis, M. | Istituto Nazionale Tumori IRCCS - Fondazione G Pascale, Napoli (Italy) |
| 6 | Im, S. A. | Seoul National University Hospital (South Korea) |
| 7 | Petrakova, K. | Masaryk Memorial Cancer Institute (Czech Republic) |
| 8 | Bianchi, G. V. | Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (Italy) |
| 9 | Martín, M. | Universidad Complutense de Madrid (Spain) |
| 10 | Nusch, A. | Practice for Hematology and Internal Oncology (Germany) |
| 11 | Sonke, G. S. | The Netherlands Cancer Institute (Netherlands) |
| 12 | De la Cruz-Merino, L. | Hospital Universitario Virgen Macarena (Spain) |
| 13 | Beck, J. T. | Highlands Oncology (United States) |
| 14 | Zarate, J. P. | Novartis International AG (Switzerland) |
| 15 | Wang, Y. | Novartis International AG (Switzerland) |
| 16 | Chakravartty, A. | Novartis International AG (Switzerland) |
| 17 | Wang, C. | Novartis International AG (Switzerland) |
| 18 | Slamon, D. J. | David Geffen School of Medicine at UCLA (United States) |
